-
Rituximab May Prevent MS if Given at Earliest Disease Signs, Mice Study Suggests
An early study suggests rituximab could be a preventive MS treatment for those at risk or with early non-motor signs, avoiding inflammation and myelin loss. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.